SCHEMBL5011876

SCHEMBL5011876

Ic1cs[c]n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3125602 0.65
SCHEMBL533958 0.65
SCHEMBL7458711 0.65
SCHEMBL533260 0.65
SCHEMBL972112 0.62
SCHEMBL314017 0.60
SCHEMBL313087 0.60
SCHEMBL314388 0.60
SCHEMBL4723588 0.60
SCHEMBL972636 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109842-A1 ACRYLAMIDE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2024-04-04 US disclosed
CN-114667280-A Acrylamide compound 大塚制药株式会社 2022-06-24 CN disclosed
WO-2021117733-A1 ACRYLAMIDE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2021-06-17 WO disclosed
CN-101163699-A Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof MEDPOINTE HEALTHCARE INC (US) 2008-04-16 CN disclosed
EP-1888570-A2 METHODS FOR SYNTHESIS OF DICARBAMATE COMPOUNDS AND INTERMEDIATES IN THE FORMATION THEREOF MedPointe Healthcare Inc. (US) 2008-02-20 EP disclosed
WO-2006116007-A2 METHODS FOR SYNTHESIS OF DICARBAMATE COMPOUNDS AND INTERMEDIATES IN THE FORMATION THEREOF MEDPOINTE HEALTHCARE INC. (US) 2006-11-02 WO disclosed
US-20060241298-A1 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof MEDPOINTE HEALTHCARE INC. 2006-10-26 US disclosed